Matthew Nicosia - 09 Jun 2022 Form 4 Insider Report for Vivakor, Inc. (VIVK)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: VIVK
Reported as of: 09 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Jun 2022, 20:19:36 UTC
Prior SEC filing: 25 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Matthew Nicosia

Key filing fact

Matthew Nicosia filed Form 4 for Vivakor, Inc. (VIVK) on 13 Jun 2022.

Key facts

This page summarizes Matthew Nicosia's Form 4 filing for Vivakor, Inc. (VIVK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Jun 2022, 20:19.

Change

Previous filing in this sequence was filed on 25 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIVK transaction Derivative

Stock Option to Purchase Common Stock

Award

Transaction value: $0
Shares: +955,093
Change %
Price: $0.000000
Shares after: 955,093
Date: 09 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 955,093
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Matthew Nicosia. Pursuant to the Agreement, the Company granted Mr. Nicosia a stock option to acquire 955,053 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 278,356 of the shares vesting immediately, 225,579 of the shares vesting three (3) months after issuance, and the remaining 451,158 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (64,451 for 6 quarters and 64,642 in the last quarter), with an exercise price equal to 110% of the fair market value on the date grant, and which expires five (5) years after the date of grant.